Press-release for stocks for endo international plc for GSK

| 157.14% | O: -14.29% H: 16.67% C: 0.0%
GLAXF | $20.2 510

| -3.02% | O: 0.82% H: 0.0% C: 0.0%
SNYNF | $92.966 630

| -0.76% | O: -1.64% H: 0.0% C: 0.0%
VTRS | $11.15 -1.5% 2.3M

| -3.58% | O: -0.34% H: 0.0% C: -1.2%
NVS | $93.29 -1.19% 530K

| -8.75% | O: -1.57% H: 0.26% C: -0.47%
GSK | $39.935 -1.4% 900K

| -3.62% | O: -0.48% H: 0.16% C: 0.0%
BAX | $39.415 -1.56% 640K

| 1.68% | O: -0.96% H: 5.91% C: 3.74%
ABT | $109.92 0.95% 3.2M

| -4.88% | O: -1.41% H: 0.0% C: 0.0%
SNY | $46.19 0.57% 580K

| -0.59% | O: -2.25% H: 0.0% C: 0.0%
AMGN | $264.955 -0.21% 880K

| -10.26% | O: 0.38% H: 0.34% C: -0.72%
america growth market

Vertigo Drugs Market Research Report 2023 - Global Industry Size, Share, Trends, Opportunity, and Forecasts, 2018-2028F
Published: 2024-02-01 (Crawled : 18:00) - prnewswire.com
ENDPQ | $0.0018 420K

| 200.0% | O: -83.33% H: 500.0% C: 500.0%
GLAXF | $20.2 510

| 1.0% | O: -0.7% H: 0.0% C: 0.0%
NVS | $93.29 -1.19% 530K

| -10.37% | O: -0.5% H: 0.26% C: -1.03%
GSK | $39.935 -1.4% 900K

| -0.32% | O: -0.05% H: 0.59% C: 0.27%
report research global market

NeuroBo Pharmaceuticals Strengthens Board of Directors with the Appointment of James P. Tursi, M.D.
Published: 2023-11-06 (Crawled : 14:30) - biospace.com/
ENDPQ | $0.0018 420K

| -64.0% | O: 40.0% H: 0.0% C: -25.71%
GLAXF | $20.2 510

| 19.17% | O: 1.89% H: 1.97% C: -0.46%
GSK | $39.935 -1.4% 900K

| 17.6% | O: 0.64% H: 0.82% C: 0.38%
NRBO | $3.53 6.9K

| 5.06% | O: 4.76% H: 0.0% C: -3.61%
pharmaceuticals

Decoding the Global Vasectomy Market 2023: Trends, Strategies, and Regulatory Insights
Published: 2023-09-04 (Crawled : 16:00) - prnewswire.com
SNY | $46.19 0.57% 580K

| Email alert Add to watchlist
GSK | $39.935 -1.4% 900K

| Email alert Add to watchlist
PFE A | $25.84 -0.27% 8.9M

| Email alert Add to watchlist
NVSEF | $93.6375 82K

| Email alert Add to watchlist
ENDP | $0.2926 -9.6%

| Email alert Add to watchlist
SNYNF | $92.966 630

| Email alert Add to watchlist
ABBV | $163.42 1.08% 2M

| Email alert Add to watchlist
GLAXF | $20.2 510

| Email alert Add to watchlist
ABT | $109.92 0.95% 3.2M

| Email alert Add to watchlist
ENDPQ | $0.0018 420K

| Email alert Add to watchlist
NVS | $93.29 -1.19% 530K

| Email alert Add to watchlist
JNJ | $144.56 -2.05% 4.3M

| Email alert Add to watchlist
TEVJF | $12.37 -24.22% 380

| Email alert Add to watchlist
global market

Global Analgesics Market 2023 - 2028: Upsurge in Healthcare Expenditure Fuels the Sector
Published: 2023-05-31 (Crawled : 00:00) - prnewswire.com
ENDPQ | $0.0018 420K

| -94.86% | O: -27.14% H: 73.73% C: 17.65%
HLNCF | $3.995 1.6K

| 0.76% | O: 1.39% H: 0.0% C: 0.0%
HLN | $8.085 0.31% 1.4M

| 0.25% | O: 0.62% H: 1.17% C: 0.74%
RBGPF | $51.8 8K

Consumer Non-Durables

| -32.88% | O: 2.95% H: 0.0% C: -1.09%
GLAXF | $20.2 510

| 21.03% | O: -0.24% H: 2.1% C: 2.1%
RBGLY | $10.49 5.1M

| -33.14% | O: 1.08% H: 0.57% C: 0.57%
TEVA | $13.09 -1.06% 3.2M

| 83.75% | O: 0.42% H: 0.83% C: -0.41%
JNJ | $144.56 -2.05% 4.3M

| -4.82% | O: -0.34% H: 0.32% C: 0.0%
GSK | $39.935 -1.4% 900K

| 20.54% | O: -0.24% H: 1.43% C: 0.84%
LLY | $745.04 -0.76% 730K

| 74.82% | O: 0.19% H: 1.52% C: 1.45%
ABT | $109.92 0.95% 3.2M

| 6.75% | O: -0.09% H: 0.97% C: 0.89%
SNY | $46.19 0.57% 580K

| -7.49% | O: -0.84% H: 0.0% C: 0.0%
global market

Global Generic Drugs Strategic Business Report 2023: Market to Reach $644.5 Billion by 2030 from $402.9 Billion in 2022 - Patent Expiries in 2020, 2021 and 2022 Set to Widen the Addressable Market
Published: 2023-03-10 (Crawled : 00:20) - prnewswire.com
ENDP | $0.2926 -9.6%

| Email alert Add to watchlist
SNYNF | $92.966 630

| Email alert Add to watchlist
ABT | $109.92 0.95% 3.2M

| Email alert Add to watchlist
TEVJF | $12.37 -24.22% 380

| Email alert Add to watchlist
ENDPQ | $0.0018 420K

| Email alert Add to watchlist
GSK | $39.935 -1.4% 900K

| Email alert Add to watchlist
BAX | $39.415 -1.56% 640K

| Email alert Add to watchlist
AZN | $68.38 -0.51% 2.1M

| Email alert Add to watchlist
LLY | $745.04 -0.76% 730K

| Email alert Add to watchlist
AZNCF | $135.94 770

| Email alert Add to watchlist
NVO | $123.64 -0.21% 1.4M

| Email alert Add to watchlist
SNY | $46.19 0.57% 580K

| Email alert Add to watchlist
GLAXF | $20.2 510

| Email alert Add to watchlist
patent global report set market

Global Best Selling Pharmaceutical Drugs Analysis Report 2023: Revenue Forecast of the Top 50 Pharmaceutical Drugs and Assessment of their Regulatory Landscape through 2021
Published: 2023-03-10 (Crawled : 20:00) - prnewswire.com
AMGN | $264.955 -0.21% 880K

| Email alert Add to watchlist
CSLLY | $89.5 44K

| Email alert Add to watchlist
MNK | News | $0.3402 -0.06% 540K

| Email alert Add to watchlist
SNY | $46.19 0.57% 580K

| Email alert Add to watchlist
GLAXF | $20.2 510

| Email alert Add to watchlist
MNKPF | News | $17.25

| Email alert Add to watchlist
ABBV | $163.42 1.08% 2M

| Email alert Add to watchlist
ENDP | $0.2926 -9.6%

| Email alert Add to watchlist
ALPMY | $9.2715 500K

| Email alert Add to watchlist
VTRS | $11.15 -1.5% 2.3M

| Email alert Add to watchlist
NVSEF | $93.6375 82K

| Email alert Add to watchlist
UCBJY | $63.0 11K

| Email alert Add to watchlist
NVS | $93.29 -1.19% 530K

| Email alert Add to watchlist
ALPMF | $9.48 1.7K

| Email alert Add to watchlist
SNYNF | $92.966 630

| Email alert Add to watchlist
BHC | $8.595 -0.41% 880K

| Email alert Add to watchlist
UCBJF | $126.05 100

| Email alert Add to watchlist
TEVJF | $12.37 -24.22% 380

| Email alert Add to watchlist
ENDPQ | $0.0018 420K

| Email alert Add to watchlist
CMXHF | $180.75 33

| Email alert Add to watchlist
JNJ | $144.56 -2.05% 4.3M

| Email alert Add to watchlist
MNKKQ | News | $0.02

| Email alert Add to watchlist
GSK | $39.935 -1.4% 900K

| Email alert Add to watchlist
NVO | $123.64 -0.21% 1.4M

| Email alert Add to watchlist
global report

Generic drugs market size to increase by USD 176.25 billion; North America to contribute 37% of market growth - Technavio
Published: 2023-01-11 (Crawled : 00:00) - prnewswire.com
ENDPQ | $0.0018 420K

| -98.03% | O: -3.17% H: 7.0% C: 1.69%
TEVJF | $12.37 -24.22% 380

| 19.06% | O: 5.87% H: 0.0% C: 0.0%
GLAXF | $20.2 510

| 15.17% | O: -0.51% H: 0.0% C: 0.0%
SNYNF | $92.966 630

| -4.54% | O: 0.37% H: 1.64% C: 1.64%
NVSEF | $93.6375 82K

| 24.23% | O: 0.37% H: 0.0% C: -0.49%
VTRS | $11.15 -1.5% 2.3M

| -3.82% | O: -0.08% H: 0.6% C: -0.85%
NVS | $93.29 -1.19% 530K

| 4.36% | O: -0.46% H: 0.91% C: 0.57%
GSK | $39.935 -1.4% 900K

| 16.82% | O: 0.2% H: 1.55% C: 1.18%
BAX | $39.415 -1.56% 640K

| -11.88% | O: -0.11% H: 0.55% C: -0.66%
ABT | $109.92 0.95% 3.2M

| -3.76% | O: -1.03% H: 0.35% C: -0.56%
SNY | $46.19 0.57% 580K

| -3.46% | O: -0.38% H: 0.0% C: 0.0%
AMGN | $264.955 -0.21% 880K

| -2.71% | O: -0.36% H: 0.27% C: -0.37%
america growth market

Outlook on the Pharmaceutical Drugs Global Market to 2027: Look at the Changing Structure of the Pharma and Healthcare Industry
Published: 2023-01-03 (Crawled : 13:00) - prnewswire.com
ENDPQ | $0.0018 420K

| -97.46% | O: -1.13% H: 28.57% C: 19.0%
CSLLY | $89.5 44K

| -8.24% | O: -3.93% H: 2.17% C: 1.75%
MNK | News | $0.3402 -0.06% 540K

| -94.75% | O: 3.1% H: 0.0% C: -2.75%
GLAXF | $20.2 510

| 15.53% | O: -0.2% H: 2.06% C: 2.06%
SNYNF | $92.966 630

| -3.44% | O: 1.09% H: 0.54% C: 0.54%
UCBJY | $63.0 11K

| 60.31% | O: 1.0% H: 0.0% C: -0.26%
ALPMY | $9.2715 500K

| -38.84% | O: 3.43% H: 0.0% C: -2.93%
VTRS | $11.15 -1.5% 2.3M

| 1.71% | O: 0.54% H: 2.5% C: 1.7%
NVO | $123.64 -0.21% 1.4M

| -8.45% | O: 1.43% H: 0.84% C: -0.23%
NVS | $93.29 -1.19% 530K

| 4.07% | O: 0.42% H: 1.35% C: 1.22%
JNJ | $144.56 -2.05% 4.3M

| -16.45% | O: -0.28% H: 1.26% C: 1.15%
GSK | $39.935 -1.4% 900K

| 15.25% | O: -0.57% H: 1.35% C: 1.0%
BHC | $8.595 -0.41% 880K

| 37.42% | O: 0.48% H: 3.96% C: -0.48%
ABBV | $163.42 1.08% 2M

| 0.04% | O: 0.27% H: 0.6% C: 0.21%
SNY | $46.19 0.57% 580K

| -3.08% | O: 0.16% H: 0.0% C: 0.0%
AMGN | $264.955 -0.21% 880K

| 1.09% | O: -0.67% H: 0.66% C: 0.3%
pharma global market

Global Transdermal Drug Delivery Systems Market to Reach $72.4 Billion by 2028 at a CAGR of 4.6%
Published: 2022-12-30 (Crawled : 17:00) - prnewswire.com
ENDPQ | $0.0018 420K

| -97.5% | O: -0.69% H: 15.36% C: -1.12%
GLAXF | $20.2 510

| 16.83% | O: 1.13% H: 0.0% C: 0.0%
VTRS | $11.15 -1.5% 2.3M

| 1.71% | O: -0.36% H: 0.81% C: 0.36%
NVS | $93.29 -1.19% 530K

| 3.07% | O: -0.01% H: 0.08% C: -0.95%
JNJ | $144.56 -2.05% 4.3M

| -16.88% | O: -0.04% H: 0.16% C: -0.47%
GSK | $39.935 -1.4% 900K

| 15.29% | O: -0.37% H: 0.89% C: 0.4%
drug global transdermal market

Endocrinology drugs market size to grow by USD 36551.24 Million: Increase in the incidence of endocrine disorders remains key growth driver - Technavio
Published: 2022-12-07 (Crawled : 00:00) - prnewswire.com
ENDPQ | $0.0018 420K

| -98.0% | O: 0.0% H: 11.11% C: 2.78%
GLAXF | $20.2 510

| 14.06% | O: 1.92% H: 0.0% C: 0.0%
SNYNF | $92.966 630

| -1.55% | O: 0.5% H: 0.16% C: 0.16%
NVSEF | $93.6375 82K

| 23.48% | O: 0.0% H: 0.0% C: 0.0%
NVS | $93.29 -1.19% 530K

| 2.92% | O: -1.17% H: 1.09% C: 1.01%
GSK | $39.935 -1.4% 900K

| 9.82% | O: -1.41% H: 1.75% C: 0.66%
ABT | $109.92 0.95% 3.2M

| 3.89% | O: -0.14% H: 2.32% C: 2.16%
SNY | $46.19 0.57% 580K

| -1.23% | O: -1.32% H: 0.0% C: 0.0%
ORMP | $2.385 -1.45% 41K

| -70.88% | O: 0.48% H: 4.55% C: 3.47%
endocrine growth market endocrine disorders

Migraine drugs market in Latin America 2023-2027: 5-Year (2017-2021) historic industry size and analysis of 15 vendors and 7 countries - Technavio
Published: 2022-12-06 (Crawled : 02:00) - prnewswire.com
ENDPQ | $0.0018 420K

| -98.06% | O: -2.59% H: 4.21% C: 2.0%
GLAXF | $20.2 510

| 17.78% | O: 2.04% H: 8.0% C: 7.71%
SNYNF | $92.966 630

| 4.63% | O: 0.74% H: 8.46% C: 8.46%
IGXT | $0.17 37K

| 9.82% | O: -6.33% H: 9.38% C: 7.52%
GSK | $39.935 -1.4% 900K

| 15.19% | O: -1.19% H: 14.39% C: 9.15%
ABBV | $163.42 1.08% 2M

| -1.38% | O: 0.05% H: 0.22% C: -0.19%
SNY | $46.19 0.57% 580K

| 4.23% | O: 0.33% H: 0.0% C: 0.0%
AMGN | $264.955 -0.21% 880K

| -6.81% | O: 0.33% H: 0.56% C: -0.89%
america migraine market

The Global Migraine Drugs Market is expected to grow by $1 bn during 2022-2026, accelerating at a CAGR of 5.74% during the forecast period
Published: 2022-11-21 (Crawled : 16:00) - prnewswire.com
ENDPQ | $0.0018 420K

| -98.16% | O: -1.63% H: 3.73% C: 3.63%
AZNCF | $135.94 770

| 6.29% | O: 3.09% H: 0.0% C: -1.59%
NVS | $93.29 -1.19% 530K

| 10.16% | O: 0.74% H: 0.89% C: 0.53%
GSK | $39.935 -1.4% 900K

| 23.14% | O: 2.04% H: 0.06% C: -0.36%
ABBV | $163.42 1.08% 2M

| 4.32% | O: 0.27% H: 2.08% C: 1.1%
ABT | $109.92 0.95% 3.2M

| 4.83% | O: -0.13% H: 1.13% C: 0.14%
SNY | $46.19 0.57% 580K

| 5.99% | O: 1.02% H: 0.0% C: 0.0%
AZN | $68.38 -0.51% 2.1M

| 5.62% | O: 0.68% H: 0.35% C: -0.12%
AMGN | $264.955 -0.21% 880K

| -7.58% | O: 0.63% H: 0.87% C: -0.32%
global expected migraine market

Neuropathy Pain Treatment Market Size to Grow by USD 3.81 Bn, Growing Focus on Emerging Economies to be a Key Trend - Technavio
Published: 2022-10-04 (Crawled : 11:00) - prnewswire.com
ENDPQ | $0.0018 420K

| -98.03% | O: -1.75% H: 17.22% C: 10.78%
ALPMF | $9.48 1.7K

| -26.85% | O: 5.79% H: 0.0% C: 0.0%
SNYNF | $92.966 630

| 22.07% | O: 8.97% H: 0.0% C: 0.0%
AZNCF | $135.94 770

| 22.19% | O: 0.45% H: 2.01% C: 1.12%
ALPMY | $9.2715 500K

| -30.76% | O: 1.34% H: 1.11% C: 1.11%
NVS | $93.29 -1.19% 530K

| 23.14% | O: 1.37% H: 1.04% C: 0.66%
GSK | $39.935 -1.4% 900K

| 33.88% | O: 1.59% H: 0.93% C: -0.07%
BAX | $39.415 -1.56% 640K

| -28.01% | O: 0.99% H: 2.56% C: 2.28%
ABT | $109.92 0.95% 3.2M

| 9.42% | O: 1.23% H: 2.45% C: 2.32%
SNY | $46.19 0.57% 580K

| 21.21% | O: 2.72% H: 0.0% C: 0.0%
BIIB | $196.6 -0.1% 350K

| -25.54% | O: 0.64% H: 1.45% C: 0.55%
AZN | $68.38 -0.51% 2.1M

| 23.73% | O: 1.42% H: 1.38% C: 1.24%
treatment growing market

Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market to Surpass US$ 20,450.6 Million by 2030 - Coherent Market Insights
Published: 2022-06-22 (Crawled : 19:00) - prnewswire.com
GLAXF | $20.2 510

| -24.8% | O: -0.14% H: 0.14% C: -2.96%
PFE A | $25.84 -0.27% 8.9M

| -47.2% | O: 0.43% H: 0.0% C: 0.0%
GSK | $39.935 -1.4% 900K

| -22.8% | O: 1.31% H: 0.59% C: 0.54%
ABBV | $163.42 1.08% 2M

| 9.56% | O: 0.57% H: 0.0% C: 0.0%
ENDP | $0.2926 -9.6%

| -18.72% | O: -2.25% H: 13.16% C: 10.83%
infections skin market

Oral Cancer Therapeutics Market - 51% of Growth to Originate from North America | Driven by Increasing Incidence & Prevalence of Oral Cancer| Technavio
Published: 2022-04-05 (Crawled : 09:00) - prnewswire.com
GLAXF | $20.2 510

| -3.12% | O: 7.19% H: 0.0% C: -2.86%
SNYNF | $92.966 630

| -13.12% | O: -0.75% H: 0.0% C: 0.0%
AZNCF | $135.94 770

| -0.24% | O: -0.97% H: 0.0% C: -0.99%
VTRS | $11.15 -1.5% 2.3M

| 4.33% | O: -0.65% H: 2.32% C: -1.02%
GSK | $39.935 -1.4% 900K

| -7.28% | O: 1.3% H: 0.0% C: 0.0%
SNY | $46.19 0.57% 580K

| -9.78% | O: 0.64% H: 0.0% C: 0.0%
ENDP | $0.2926 -9.6%

| -87.81% | O: -1.25% H: 3.8% C: -3.8%
AZN | $68.38 -0.51% 2.1M

| 3.09% | O: 0.39% H: 1.79% C: 0.18%
america therapeutics cancer growth market

Erectile Dysfunction (ED) Drugs Market: 4.76% Y-O-Y Growth Rate in 2022 | By Product (oral drugs, topical drugs, and others) and Geography | Growth, Trends, and Forecasts (2022 - 2026)
Published: 2022-03-24 (Crawled : 01:00) - prnewswire.com
GLAXF | $20.2 510

| -5.03% | O: -2.44% H: 0.0% C: -0.92%
VTRS | $11.15 -1.5% 2.3M

| 4.04% | O: 0.46% H: 0.69% C: 0.18%
GSK | $39.935 -1.4% 900K

| -5.97% | O: 0.23% H: 0.0% C: 0.0%
ENDP | $0.2926 -9.6%

| -87.71% | O: 1.26% H: 0.79% C: -2.07%
growth drug

Central Nervous System (CNS) Stimulant Drugs Market to grow at a CAGR of 5.74 by 2026 | Rise in CNS Disorders to Boost Growth | 17000+ Technavio Reports
Published: 2022-03-14 (Crawled : 16:00) - prnewswire.com
ALPMF | $9.48 1.7K

| -39.62% | O: 0.7% H: 0.0% C: 0.0%
GLAXF | $20.2 510

| 5.54% | O: 9.61% H: 0.0% C: -0.57%
SNYNF | $92.966 630

| -12.02% | O: -2.53% H: 0.0% C: -0.08%
NVSEF | $93.6375 82K

| 11.54% | O: -3.28% H: 0.0% C: 0.0%
ALPMY | $9.2715 500K

| -40.91% | O: 2.42% H: 0.31% C: -0.47%
KMPH | $5.46 6.04% 0

| 12.62% | O: 0.0% H: 1.34% C: -4.4%
VTRS | $11.15 -1.5% 2.3M

| 12.97% | O: 1.4% H: 1.08% C: -3.44%
TMO | $555.75 -0.38% 380K

| 2.93% | O: -1.31% H: 0.0% C: 0.0%
NVS | $93.29 -1.19% 530K

| 13.26% | O: 0.54% H: 0.0% C: 0.0%
GSK | $39.935 -1.4% 900K

| -0.86% | O: 0.42% H: 0.0% C: 0.0%
SNY | $46.19 0.57% 580K

| -9.13% | O: -3.24% H: 0.0% C: 0.0%
JAZZ | $110.13 -0.7% 190K

| -28.3% | O: 0.1% H: 1.14% C: -0.59%
ENDP | $0.2926 -9.6%

| -87.39% | O: -1.72% H: 3.51% C: -5.26%
BIIB | $196.6 -0.1% 350K

| -0.44% | O: 0.47% H: 1.48% C: -2.43%
order drug system nervous system report growth

Worldwide Pain Management Drugs Industry to 2026 - Featuring Abbott Laboratories, Pfizer and Allergen Among Others
Published: 2021-06-23 (Crawled : 22:00) - prnewswire.com
PFE A | $25.84 -0.27% 8.9M

| -33.65% | O: 0.23% H: 0.52% C: 0.13%
JNJ | $144.56 -2.05% 4.3M

| -9.25% | O: 0.39% H: 0.57% C: 0.06%
GSK | $39.935 -1.4% 900K

| 1.63% | O: -0.68% H: 1.01% C: 0.3%
ABT | $109.92 0.95% 3.2M

| -1.76% | O: 0.6% H: 1.78% C: 0.18%
ENDP | $0.2926 -9.6%

| -93.81% | O: 0.42% H: 3.37% C: 2.95%
drug

Gainers vs Losers

53%

47%

Top 10 Gainers

WISA 4 | $7.86 349.14% 120M

Electronic Technology

TPET | $0.4951 114.24% 29M

PRSO | $1.99 56.69% 52M

PALI | $6.5 56.25% 22M

JAGX | $0.1767 48.74% 430M

SXTC | $2.03 45.0% 27M

SPCB | $0.3888 40.87% 27M

Electronic Technology

DYNT | $0.52 40.39% 20M

SNGX | $0.54 39.86% 7.3M

BSGM | $1.53 39.09% 2.6M